newsfilter
← Latest News
PR Newswire·

Nasdaq Approves 180-Day Extension for Virax Biolabs Group to Meet Minimum $1 Bid

LONDON, Aug. 3, 2023 /PRNewswire/ -- Virax Biolabs Group Limited ("Virax" or the "Company") (NASDAQ:VRAX), an innovative diagnostics company focused on the detection of immune responses and diagnosis of